| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |